A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women

1999 ◽  
Vol 340 (22) ◽  
pp. 1723-1731 ◽  
Author(s):  
Jamal A. Ibdah ◽  
Michael J. Bennett ◽  
Piero Rinaldo ◽  
Yiwen Zhao ◽  
Beverly Gibson ◽  
...  
1999 ◽  
Vol 54 (11) ◽  
pp. 679
Author(s):  
Jamal A. Ibdah ◽  
Michael J. Bennett ◽  
Piero Rinaldo ◽  
Yiwen Zhao ◽  
Beverly Gibson ◽  
...  

2017 ◽  
Vol 66 (1) ◽  
pp. 132-141 ◽  
Author(s):  
Karim Gariani ◽  
Dongryeol Ryu ◽  
Keir J. Menzies ◽  
Hyon-Seung Yi ◽  
Sokrates Stein ◽  
...  

2003 ◽  
Vol 142 (6) ◽  
pp. 684-689 ◽  
Author(s):  
Margarethe E.J. den Boer ◽  
Carlo Dionisi-Vici ◽  
Anupam Chakrapani ◽  
Anders O.J. van Thuijl ◽  
Ronald J.A. Wanders ◽  
...  

1993 ◽  
Vol 39 (5) ◽  
pp. 897-901 ◽  
Author(s):  
M J Bennett ◽  
W G Sherwood

Abstract Three patients presented with evidence of a fatty acid oxidation disorder. Analysis of urinary organic acids by gas chromatography/mass spectrometry demonstrated the presence of medium-chain (C6-C12) dicarboxylic, 3-hydroxydicarboxylic, and 3-ketodicarboxylic acids in all three urines. 3-Ketodicarboxylic aciduria is reported for the first time here, as are the mass spectra for 3-ketosuberic, 3-ketosebacic, and 3-ketododecanedioic acids and the oximated spectrum for 3-ketoadipic acid. The presence of 3-ketodicarboxylic acids suggests a defect at the level of a long-chain 3-ketoacyl-CoA thiolase, an enzyme for which a deficiency state has not previously been described. Our patients may represent the first cases of a long-chain thiolase defect.


2016 ◽  
Vol 36 (20) ◽  
pp. 2553-2567 ◽  
Author(s):  
Liang Guo ◽  
Shui-Rong Zhou ◽  
Xiang-Bo Wei ◽  
Yuan Liu ◽  
Xin-Xia Chang ◽  
...  

Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease, and decreased fatty acid oxidation is one of the important contributors to NAFLD. Mitochondrial trifunctional protein α-subunit (MTPα) functions as a critical enzyme for fatty acid β-oxidation, but whether dysregulation of MTPα is pathogenically connected to NAFLD is poorly understood. We show that MTPα is acetylated at lysine residues 350, 383, and 406 (MTPα-3K), which promotes its protein stability by antagonizing its ubiquitylation on the same three lysines (MTPα-3K) and blocking its subsequent degradation. Sirtuin 4 (SIRT4) has been identified as the deacetylase, deacetylating and destabilizing MTPα. Replacement of MTPα-3K with either MTPα-3KR or MTPα-3KQ inhibits cellular lipid accumulation both in free fatty acid (FFA)-treated alpha mouse liver 12 (AML12) cells and primary hepatocytes and in the livers of high-fat/high-sucrose (HF/HS) diet-fed mice. Moreover, knockdown of SIRT4 could phenocopy the effects of MTPα-3K mutant expression in mouse livers, and MTPα-3K mutants more efficiently attenuate SIRT4-mediated hepatic steatosis in HF/HS diet-fed mice. Importantly, acetylation of both MTPα and MTPα-3K is decreased while SIRT4 is increased in the livers of mice and humans with NAFLD. Our study reveals a novel mechanism of MTPα regulation by acetylation and ubiquitylation and a direct functional link of this regulation to NAFLD.


2006 ◽  
Vol 107 (1) ◽  
pp. 115-120 ◽  
Author(s):  
Marsha F. Browning ◽  
Harvey L. Levy ◽  
Louise E. Wilkins-Haug ◽  
Cecilia Larson ◽  
Vivian E. Shih

Sign in / Sign up

Export Citation Format

Share Document